Enlight Energy — Director's Dealing 2026

May 26, 2026

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

☐ Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL
OMB Number:	3235-0287
Estimated average burden hours per response	0.5

☐ Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person* Paz Amit (Last) (First) (Middle) C/O ENLIGHT RENEWABLE ENERGY LTD. 13 AMAL ST. AFEK INDUSTRIAL PARK (Street) ROSH HAAYIN 4809249 (City) (State) (Zip/Postal Code) ISRAEL (Country)		2. Issuer Name and Ticker or Trading Symbol Enlight Renewable Energy Ltd. [ ENLT ] 2a. Foreign Trading Symbol ENLT 3. Date of Earliest Transaction (Month/Day/Year) 05/26/2026 4. If Amendment, Date of Original Filed (Month/Day/Year)	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director 10% Owner X Officer (give title below) Other (specify below) CHIEF INNOVATION OFFICER 6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person
---	---	---	---
Table I – Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)
			Code
Ordinary shares, NIS 0.1 par value per share	05/26/2026		S

---

| Table II – Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities) | | | | | | | | | | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security (Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date (Month/Day/Year) | 3A. Deemed Execution Date, if any (Month/Day/Year) | 4. Transaction Code (Instr. 8) | | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) | | 6. Date Exercisable and Expiration Date (Month/Day/Year) | | 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) | | 8. Price of Derivative Security (Instr. 5) | 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) |
| | | | | Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | | |
| Stock Options (right to buy) | $27.33(3) | | | | | | | (4) | 10/01/2032 | Ordinary shares, NIS 0.1 par value per share | 44,884(5) | $0 | 44,884(5) |

Explanation of Responses:

1. Represents a transaction price of NIS 283.00, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 2.907 as of the date immediately preceding the date of the transaction.
2. Includes (i) 12,627 restricted share units granted on April 24, 2024, with 6,313 vesting on April 24, 2027 and 6,314 vesting on April 21, 2028; and (ii) 9,868 restricted share units granted on October 1, 2025, with 2,467 vesting on each of October 1, 2026, October 1, 2027, October 1,2028, and October 1, 2029. Each restricted share unit represents a contingent right to receive one ordinary share of the Company.
3. Represents an exercise price of NIS 84.60, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 3.096 as of March 18, 2026.
4. Stock options were granted on October 1, 2025, with 11,221 vesting on each of October 1, 2026, October 1, 2027, October 1, 2028, and October 1, 2029.
5. No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only.

/s/ Helit Megido as attorney-in-fact for Amit Paz 05/26/2026

** Signature of Reporting Person

Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

• If the form is filed by more than one reporting person, see Instruction 4(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.